drugset / Trial / NCT00817544

Excretion Balance and Metabolism After a Single Oral Dose of 14C-Labelled ORM-12741

NCT00817544 ↗

Phase 1 Completed 6 enrolled Orion Corporation, Orion Pharma
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The study is conducted to examine absorption of C14-ORM-12741 from intestine to bloodstream, distribution to bloodstream, metabolism in the liver and excretion of the parent drug and metabolites to faeces, urine and expired air

Timeline

Start
2009-01
Primary completion
2009-02
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ORM-12741 Small molecule 3 mg Oral

Indications

No indication recorded.